-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

731. Autologous Transplantation: Clinical and Epidemiological: Poster III

Program: Oral and Poster Abstracts
Type: Poster
Monday, December 13, 2021: 6:00 PM-8:00 PM
Hall B5, Level 1, Building B (Georgia World Congress Center)

Shanee Chung, MBChB, FRACP, FRCPA1, Jennifer White, MD, MSc, FRCPC2*, Cynthia L. Toze, MD, FRCPC, MSc3*, Heather J. Sutherland, MD, PhD, FRCPC3, David Sanford, MD, FRCPC3, Judith Anula Rodrigo, MD, FRCPC4*, Thomas J. Nevill, MD, FRCPC2, Sujaatha Narayanan, MBBS, MRCP, MRCPath2*, Stephen H. Nantel, MD, FRCPC3, Florian Kuchenbauer, MD, PhD, FRCPC3, Kevin A. Hay, MD, MSc, FRCPC2, Donna L. Forrest, MD, FRCPC2, Yasser Abou Mourad, MD, FRCPC, FACP3, Kevin Song, MD, FRCPC2 and Maryse Power, MB, FRCPI, FRCPath3

1The Leukemia/Bone Marrow Transplant Program of British Columbia, British Columba Cancer Agency, Vancouver, BC, Canada
2The Leukemia/Bone Marrow Transplant Program of British Columbia, British Columbia Cancer Agency, Vancouver, Canada
3The Leukemia/Bone Marrow Transplant Program of British Columbia, British Columbia Cancer Agency, Vancouver, BC, Canada
4The Leukemia/Bone Marrow Transplant Program of British Columbia, British Columbia Cancer Agency, Vancouver, BC, CAN

Luis F. Porrata, MD1, David J. Inwards, MD1, Stephen M. Ansell, MD, PhD1, Ivana N. Micallef, MD1, Patrick B. Johnston, M.D., Ph.D.1, Jose C. Villasboas, MD1, Jonas Paludo, MD1 and Svetomir N. Markovic, MD, PhD2

1Division of Hematology, Mayo Clinic, Rochester, MN
2Division of Medical Oncology, Mayo Clinic, Rochester, MN

Meral Beksac, MD1, Simona Iacobelli2*, Linda Koster3*, Didier Blaise4, Jan J. Cornelissen, MD, PhD5, Péter Reményi6*, Xavier Leleu, MD7, Tobias Gedde-Dahl, MD8*, Xavier Poire, MD9*, Laimonas Griskevicius10*, Edouard Forcade, MD, PhD11*, Stig Lenhoff12*, Neil K Rabin, MD, PhD13*, Guido Kobbe, MD14*, Tanja Netelenbos, MD, PhD15,16, William Arcese, MD, PhD17, Jean-Baptiste Mear18*, Monika Engelhardt, MD19, Thomas Pabst, MD20, Nicolaas Schaap, MD, PhD21, Claudia Lucia Sossa22*, Ahmet Elmaagacli, MD23*, Patrick John Hayden, MD24, Stefan Schoenland25* and Ibrahim Yakoub-Agha26

1Department of Hematology, Ankara University School of Medicine, Ankara, Turkey
2Rome University Tor Vergata, Rome, Italy
3EBMT Data Office, Leiden, Netherlands
4Department of Hematology, Institut Paoli Calmettes, Marseille, France
5Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, Netherlands
6Dept. Haematology and Stem Cell Transplant, Albert, Dél-pesti Centrumkórház –Országos Hematológiai és Infektológiai Intézet, Budapest, Hungary
7Service D'Hématologie Et Thérapie Cellulaire, Poitiers, France
8Department of Haematology, Oslo University Hospital, Oslo, Norway
9Section of Hematology, Cliniques Universitaires Saint-Luc, Brussels, Belgium
10Vilnius University Hospital Santariskiu Clinics, Vilnius, Na, LTU
11Service d'Hématologie Clinique et Thérapie Cellulaire, CHU Bordeaux, F-33000, Bordeaux, France, CHU Bordeaux, Hospital Haut-Leveque, Pessac, FRA
12Skanes University Hospital, Lund, Sweden
13Department of Haematology, University College London Hospitals NHS Foundation Trust, London, United Kingdom
14Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany
15Department of Immunohematology and Blood Transfusion, LUMC, Leiden, NLD
16Hague Teaching Hospital, The Hague, Netherlands
17Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
18Service d’Hématologie Clinique Adulte, Centre Hospitalier Universitaire de Rennes, Rennes, France
19Department of Medicine I Hematology and Oncology, University of Freiburg Medical Center, Freiburg, Germany
20Department of Medical Oncology, University Hospital, Bern, Switzerland
21Department of Hematology, Radboud University Medical Centre, Nijmegen, Netherlands
22Hematology and Hematopoietic Stem Cell Transplantation Unit, Clinica FOSCAL, Floridablanca, Santander, Colombia
23Department of Hematology Oncology and Stem Cell Transplantation, Asklepios Klinik St. Georg, Hamburg, Germany
24Department of Haematology, Trinity College Dublin, St.James Hospital, Foxrock, Dublin, Ireland
25University of Heidelberg, Heidelberg, Germany
26Centre Hospitalier Universitaire de Lille LIRIC, INSERM U1286, Université de Lille, Lille, France

Andrzej Jakubowiak1, Saad Z. Usmani, MD MBA FACP2, Jesus G. Berdeja3, Mounzer Agha4, Adam D Cohen5, Parameswaran Hari6, Jordan M. Schecter7, Deepu Madduri7*, Tzu-Min Yeh7*, Yunsi Olyslager8*, Arnob Banerjee9*, Carolyn C. Jackson7*, Alicia Allred9*, Enrique Zudaire9*, William Deraedt10*, Changwei Zhou11*, Dong Geng11*, Lida Pacaud11*, Yi Lin12, Thomas Martin, MD13 and Sundar Jagannath, MD14*

1University of Chicago, Chicago, IL
2Levine Cancer Institute, New York, NY
3Sarah Cannon Research Institute, Nashville, TN
4UPMC Hillman Cancer Center, Pittsburgh, PA
5Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
6Medical College of Wisconsin, Milwaukee, WI
7Janssen R&D, Raritan, NJ
8Janssen Pharmaceutica NV, Beerse, Belgium
9Janssen R&D, Spring House, PA
10Janssen R&D, Beerse, Belgium
11Legend Biotech USA, Piscataway, NJ
12Mayo Clinic, Rochester, MN
13UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA
14Mount Sinai Medical Center, New York, NY

Jakob Nordberg Nørgaard, MD1,2,3*, Niels Abildgaard, M.D.4,5, Anna Lysén, MSc1,3*, Galina Tsykunova6*, Annette Juul Vangsted, MD7*, Cristina João, MD, PhD, MSc8*, Nora Remen1*, James P Connelly, MD9*, Mona-Elisabeth R. Revheim, MD PhD2,9* and Fredrik H. Schjesvold, MD, PhD1,3

1Oslo Myeloma Center, Department of Hematology, Oslo University Hospital, Oslo, Norway
2Institute of Clinical Medicine, University of Oslo, Oslo, Norway
3KG Jebsen Center for B Cell Malignancies, University of Oslo, Oslo, Norway
4Department of Hematology, Odense University Hospital, Odense, Denmark
5Clinical Institute, University of Southern Denmark, Odense, Denmark
6Department of Hematology, Haukeland University Hospital, Bergen, Norway
7Department of Hematology, Rigshopitalet, Copenhagen, Denmark
8Department of Hematology, Champalimaud Centre for the Unknown, Lisbon, Portugal
9Division for Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway

Alicia Bao, BS1, Qiuhong Zhao, MS2*, Nidhi Sharma, PhD3*, Naresh Bumma, MD4, Srinivas Devarakonda, MD5, Abdullah Khan, MBBS, MSc6, Ashley E. Rosko, MD2, Don M Benson Jr., MD7 and Francesca Cottini, MD4

1College of Medicine, The Ohio State University College of Medicine, Columbus, OH
2Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
3The Ohio State University, Columbus, OH
4Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH
5The Ohio State University Wexner Medical Center, Columbus, OH
6Department of Internal Medicine - Hematology, The Ohio State University, Columbus, OH
7Riney Family Myeloma Center for Research Excellence, Ohio State University Medical Center, Columbus, OH

Qaiser Bashir, MD1, Peter F. Thall2*, Dawen Sui3*, Jeremy L Ramdial, MD1*, Samer A Srour4, Rohtesh S. Mehta, MD, MPH, MS1, Uday R. Popat, MD5, Yago Nieto, MD5, Neeraj Saini, MD1, Partow Kebriaei, MD5, Elisabet E. Manasanch, MD6, Hans C. Lee, MD7, Gregory P. Kaufman, MD6, Sheeba K Thomas, MD, MS8, Krina K. Patel, MD, MSc9, Robert Z. Orlowski10, Cristina G. Knape1*, Jitesh D. Kawedia, BPharm11*, Richard E Champlin, MD5, Elizabeth J Shpall, MD5, Xiaoqian Liu11* and Muzaffar H. Qazilbash, MD5

1Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Biostatistics, The University of Texas M.D. Anderson Cancer Center, Houston, TX
4Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, Houston, TX
5Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
6Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
7MD Anderson Cancer Center, Houston, TX
8Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
9MD Anderson Cancer Center, University of Texas, Houston, TX
10The University of Texas MD Anderson Cancer Center, Houston, TX
11Department of Pharmacy Pharmacology Research, The University of Texas MD Anderson Cancer Center, Houston, TX

Simon Husby1*, Gustav Ørting Jørgensen2*, Francesco Favero3*, Jakob Schmidt Jespersen4*, German G.R. Gonzalez, PhD5*, Christian Nielsen, PhD6*, Betina Sørensen, MD7*, Lene Hyldahl Ebbesen, MD, PhD8*, John Bæch, MD9*, Eva Kannik Hastrup, MD, PhD10*, Pär L. Josefsson, MD11, Michael Thorsgaard, MD12*, Tarec Christoffer Christoffer El-Galaly, MD, DSc13, Peter de Nully Brown, MD, PhD14*, Thomas Stauffer Larsen15*, Joachim Weisenfeldt, PhD5* and Kirsten Grønbæk, Prof, MD, DMSc16

1Rigshospitalet, Copenhagen N, DNK
2Rigshospitalet, Copenhagen N, Denmark
3Biotech Research & Innovation Center (BRIC), Copenhagen, Alabama, DNK
4Biotech Research and Innovation Center, University of Copenhagen, København N, Denmark
5Biotech Research & Innovation Center, University of Copenhagen, Copenhagen, Denmark
6Dept. of Clinical Immunology, Odense University Hospital, Odense, Denmark
7Dept. of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark
8Department of Hematology, Aarhus University Hospital, Aarhus, Denmark
9Dept. of Clinical Immunology, Aalborg University Hospital, Aalborg, Denmark
10Dept. of Clinical Immunology, Rigshospitalet, Copenhagen, Denmark
11Department of Hematology, Copenhagen University Hospital (Rigshospitalet), Herlev, Denmark
12Department of Internal Medicine, Vejle Regional Hospital, Vejle, Denmark
13Department of Hematology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark
14Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
15Department of Hematology X, Odense University Hospital, Odense C, Denmark
16The Epi-/Genome Laboratory, Department of Hematology, Rigshospitalet, Copenhagen, Denmark

Edvan De Queiroz Crusoe, MD, PhD1,2, Joanna Leal, MD3*, Marco Aurelio Salvino, MD, PhD4, Larissa Ferreira Lucas, MD5*, Juliana Andrade Santos, MD6,7*, Herbert Henrique de Melo Santos, MD8*, Alessandro de M. Almeida, MD9, Allan de souza Santos, BS10*, Marcos Chaves, MD11*, Mariane Melo Santos, BS, MsC12*, Sarah Queiroz Silva, MD13*, Lucas de Oliveira Vieira, MD14*, Cleverson Alves Fonseca, Pham15*, Elisangela Adorno, Pham, PhD16*, Vania Hungria17,18 and Maria da Gloria B. Arruda, MD, PhD19*

1Rua Dra Doutro Vianna S/n, Universidade Federal da Bahia- Hospital Universitario, Salvador, Brazil
2Hematology department- D'or Oncologia, Clinica CEHON Rede D'or Oncologia, Salvador, Brazil
3Hematology, Hematology Rede D'or oncologia, salvador, Brazil
4Universidade Federal De Bahia, Salvador, Brazil
5Hematology, CLinica CEHON Rede D'or Oncologia, salvador, Brazil
6Hematology, Clinica CEHON Rede D'or oncologia, Salvador, Brazil
7Federal University of Bahia, Salvador, Brazil
8Immunology, molecullar and Cytometry Laboratory- ICS, Federal University of Bahia, Salvador, Brazil
9Stem Cell Transplant Unit, Federal University of Bahia, Salvador, Brazil
10Immunology, mollecular and cytometry Laboratory- ICS, Federal University of Bahia, Salvador, Brazil
11Federal University of Bahia- Hematology and Hemotheraphy, salvador, Brazil
12Immunology, mollecullar and cytometry Laboratory- ICS, Federal University of Bahia, salvador, Brazil
13Hematology, Rede D'or Oncologia- Salvador, Salvador, Brazil
14Nuclear Medicin, Rede D'or Oncologia, Salvador, Brazil
15Faculty of Pharmacy, Federal University of Bahia, Salvador, Brazil
16Faculty of Phamacy, Federal University of Bahia, salvador, Brazil
17Hematology, Santa Casa Medical School, São Paulo, Brazil
18São Germano Clinic, São Paulo, Brazil
19Hematology, Clinica CEHON Rede D'or Oncologia, salvador, Brazil

Mesire Aydin1*, Man Wai Tang, PhD1*, Marielle Wondergem, MD1, David C. de Leeuw, MD, PhD1*, Jurgen J. Wegman, MD1*, Bart J. Biemond, MD, PhD1, Niels W.C.J. van de Donk1, Sonja Zweegman1, Ellen Meijer, MD, PhD1 and Erfan Nur, MD, PhD1,2

1Department of Hematology, Amsterdam University Medical Centers, Amsterdam, Netherlands
2Department or Blood Cell Research, Sanquin Research, Amsterdam, Netherlands

Qian Sun1* and Juan Li, PhD2

1The first affiliated hospital of Sun Yat-sen University, Guangzhou, China
2The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou , Guangdong, China

Takeshi Yoroidaka, MD1,2*, Hiroyuki Takamatsu, MD, PhD2, Mitsuhiro Itagaki, MD3*, Satoshi Yoshihara, MD, PhD4*, Kota Sato, MD5*, Naoki Takezako, MD, PhD6, Shuji Ozaki, MD, PhD7, Kazuhito Suzuki, MD8*, Kentaro Kohno, MD9*, Morio Matsumoto10*, Yasushi Terasaki11*, Takeshi Yamashita, MD12*, Shin-ichi Fuchida, MD, PhD13*, Ryota Urushihara2*, Yuji Hiragori14*, Kenshi Suzuki, MD, PhD5, Hirokazu Murakami, MD PhD15, Shinji Nakao, MD, PhD2, Brian G.M. Durie, MD16 and Kazuyuki Shimizu, MD, PhD17*

1Department of Hematology, Ishikawa Central Prefectural Hospital, Kanazawa, Japan
2Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan
3Department of Hematology, Hiroshima Red Cross Hospital and Atomic-bomb Survivors Hospital, Hiroshima, Japan
4Department of Hematology, Hyogo College of Medicine, Nishinomiya, Japan
5Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan
6Department of Hematology, National Hospital Organization Disaster Medical Center of Japan, Tachikawa, Japan
7Department of Hematology, Tokushima Prefectural Central Hospital, Tokushima, Japan
8Division of Clinical Oncology/Hematology, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan
9Department of Hematology, Japan Community Health care Organization Kyusyu Hospital, Kitakyushu, Japan
10Department of Hematology, Shibukawa Medical Center, Shibukawa, Japan
11Division of Hematology, Toyama City Hospital, Toyama, Toyama, Japan
12Division of Internal Medicine, Keiju Kanazawa Hospital, Kanazawa, ISH, JPN
13Department of Hematology, Japan Community Health care Organization Kyoto Kuramaguchi Medical Center, Kyoto, Japan
14Bio Medical Laboratories (BML), INC., Kawagoe, Japan
15Faculty of Medical Technology and Clinical Engineering, Gunma University of Health and Welfare, Maebashi, Japan
16Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Outpatient Cancer Center, Los Angeles, CA
17Department of Hematology/ Oncology, Higashi Nagoya National Hospital, Nagoya, Japan

Philipp Gödel, MD1*, Nadine Kutsch, MD1*, Jan-Michel Heger1*, Christof Scheid2, Peter Borchmann, MD1, Udo Holtick, MD, PhD3*, Gerhard Held4*, Lorenz Thurner, MD5*, Moritz Bewarder, MD6*, Torben Rixecker4*, Jörg Bittenbring4* and Dominic Kaddu-Mulindwa, MD4*

1Center for Integrated Oncology Aachen Bonn Köln Duesseldorf (CIO ABCD), Cologne Essen Lymphoma Working Group, Department I of Internal Medicine, University Hospital of Cologne, University of Cologne, Cologne, Germany
2University of Cologne, Cologne, Germany
3Department I of Internal Medicine, Leukapheresis and Stem Cell Transplant Unit, University of Cologne, Cologne, Germany
4Department of Hematology, Oncology, Clinical Immunology, Rheumatology, Medical School, University of Saarland, Homburg, Germany
5Saarland University Medical School, Homburg, Germany
6Department of Oncology, Hematology, Rheumatology and Clinical Immunology, Saarland University Medical Center, Homburg, Germany

Ehsan Malek, MD1, Farhad Sanati2*, Amanda Lauren3*, Leland Metheny III, MD4, Molly Gallogly, MD, PhD5, Mauricio Retuerto, MS6* and Mahmoud Ghannoum, PhD6*

1Adult Hematologic Malignancies & Stem Cell Transplant Section, Seidman Cancer Center, University Hospitals Cleveland Medical Center, Cleveland, OH
2University Hospitals Cleveland Medical Centers, Cleveland, OH
3University Hospitals Cleveland Medical Center, Celveland, OH
4Adult Hematologic Malignancies & Stem Cell Transplant Section, University Hospitals Seidman Cancer Center, Cleveland, OH
5Hematologic Malignancies Program, University Hospitals Seidman Cancer Center and Case Western Reserve University, Cleveland, OH
6Case Western Reserve University, Cleveland, OH

Mark Fesler, MD1, Mackenzie J Poole2*, Linda Goldenberg, ANP, MSN3*, Alexis Guennette, DO2* and Kara J Christopher, Ph.D4*

1St. Louis Univ., Saint Louis, MO
2Saint Louis University School of Medicine, St. Louis, MO
3St. Louis University School of Medicine, St Louis, MO
4Saint Louis University, St. Louis, MO

Ryota Urushihara1*, Naoki Takezako, MD, PhD2, Takeshi Yoroidaka, MD1*, Takeshi Yamashita, MD3*, Shinji Nakao, MD, PhD1 and Hiroyuki Takamatsu, MD, PhD1

1Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan
2Department of Hematology, Disaster Medical Center of Japan, Tachikawa, Japan
3Division of Internal Medicine, Keiju Kanazawa Hospital, Kanazawa, ISH, JPN

*signifies non-member of ASH